Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CareMore-AI study
NL-OMON47479Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2015
- Countries
- 1
01
Overview
Open-label trial in breast cancer (3 arms), sponsored by Erasmus MC. Primary endpoint: 6-month progression-free rate. Started Mar 2015; status: active, not recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON47479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47479.